Reset Health
Reset Health is a London-based digital health company that designs metabolic care programmes and a proprietary technology platform for treating obesity, Type 2 diabetes, and related chronic conditions, serving NHS trusts, employers, pharmaceutical companies, and private healthcare providers through NHS partnerships, white-label deployments, and direct-to-consumer subscriptions.
- Company typePrivate
- Founded2019
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2B and B2C
- OfferingServices
What Reset Health does
Reset Health is a London-based digital health company founded in 2019 that designs metabolic care programmes and a proprietary technology platform to treat obesity, Type 2 diabetes, and metabolic syndrome as chronic conditions. The company's core offering is the Reset Technology Platform (RTP), a digital clinical system that connects patients with multidisciplinary teams of doctors, dietitians, nurses, and psychologists, supporting virtual consultations, clinical messaging, behaviour change tools, and long-term outcome monitoring. On top of this platform sits the Roczen programme — a digitally delivered, clinician-led weight management intervention built around time-restricted eating, behavioural coaching, and peer support — and Roczen Plus, which bundles GLP-1/GIP and GLP-1 pharmacotherapy (Wegovy, Mounjaro) with the same clinical wraparound. The platform can be deployed as a white-labelled app or co-branded service, enabling tailored partner integrations.
Reset Health firmographics
Firmographics- Name
- Reset Health
- Legal name
- Reset Health Limited
- Website
- https://resethealth.clinic
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Reset Health is a London-based digital health company that designs metabolic care programmes and a proprietary technology platform for treating obesity, Type 2 diabetes, and related chronic conditions, serving NHS trusts, employers, pharmaceutical companies, and private healthcare providers through NHS partnerships, white-label deployments, and direct-to-consumer subscriptions.
- Ownership category
- akta.pro rank
Reset Health industry classification
Industry- Product category
- Digital Health Services
- NAICS
- Diet and Weight Reducing Centers (812191), All Other Outpatient Care Centers (621498)
- SIC
- Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)
- akta.pro secondary industries
- Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing (HLALAIAH), Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN) (HLALADAD), Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD) (HLACAGAG)
Keywords
Where Reset Health is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Reset Health business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- NHS and Health System Contracts: Reset Health partners with NHS trusts, ICBs, and national health systems to deliver structured, scalable obesity care programmes. Revenue is generated through service agreements with public health systems, providing clinical governance, technology infrastructure, and multidisciplinary expertise.
- Employer Health Benefits: Reset Health provides organisations with specialist, clinically led care for obesity and related chronic conditions as part of employee health benefits. Employers pay for access to the platform and clinical services to support workforce wellbeing.
- Pharma & Life Sciences Partnerships: Reset Health supports life sciences partners to deliver clinically governed patient programmes in real-world settings. Services include therapy initiation support, post-market surveillance, side-effect management, pharmacovigilance, and real-world data capture that demonstrates value for pharmaceutical partners.
- Direct-to-Consumer (Roczen Plus): Individual patients subscribe to the Roczen Plus medication-assisted weight loss programme starting from £195 per month. The subscription includes doctor-prescribed weekly doses of medication, 1-1 guidance from clinical team, monthly check-ins, personalised diet and exercise plans, and app access.
- Private Provider Partnerships: Reset Health extends and strengthens existing services for pharmacy networks, independent providers, and academic partners through its platform, combining clinical governance, technology infrastructure, and multidisciplinary expertise.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Roczen Plus medication-assisted programme |
Go-to-market motion1 record
Distribution channels8 records
Marketing channels8 records
Reset Health product offering
Product offeringCore offering
Reset Health designs and delivers clinically led, technology-enabled chronic care programmes for obesity, type 2 diabetes, and metabolic syndrome through its proprietary Reset Technology Platform (RTP) and Roczen care model. It combines multidisciplinary clinical teams (doctors, dietitians, nurses, psychologists) with a digital platform, offering B2B partnerships (NHS health systems, employers, pharmaceutical companies, private providers) as well as direct-to-consumer subscription services (Roczen Plus). The platform supports white-label deployment and integrates GLP-1/GIP pharmacotherapy with structured behavioural and dietary interventions.
Product overview
Reset Health delivers integrated chronic care through a platform-plus-products architecture. The Reset Technology Platform (RTP) serves as the core infrastructure—a proprietary digital clinical system that connects patients with multidisciplinary teams and enables scalable, evidence-based care delivery across health systems, employers, pharma, and private providers. Built on RTP, Roczen is the primary clinical service brand: a doctor-led, digitally delivered weight management programme for obesity and related metabolic conditions, combining time-restricted eating, behavioural coaching, peer support, and whole-food dietary guidance via a mobile app. Roczen Plus extends the programme by integrating GLP-1/GIP and GLP-1 pharmacotherapy (Wegovy, Mounjaro) with the same clinical wraparound care, targeting sustained weight loss and long-term maintenance. RTP supports flexible deployment—as a white-labelled app or co-branded service—to meet partner needs.
Differentiator
Problem solved
Functional benefit
Brands
- Roczen: Integrated care model for metabolic health delivering weight management programmes, including time-restricted eating protocols and lifestyle interventions alongside GLP-1 medications
- Roczen Plus
- Reset Technology Platform (RTP)
Products and services
- Reset Technology Platform (RTP) Proprietary cohesive digital clinical system designed to optimise therapeutic care for chronic conditions including obesity and Type 2 diabetes. Connects patients with multidisciplinary clinical teams (doctors, dietitians, nurses, psychologists), enables virtual consultations, clinical messaging, referral processing, and long-term outcome monitoring. Can be deployed as a fully white-labelled app or co-branded service for partners (NHS, employers, pharma, private providers).
- Roczen Digital, clinically led weight management programme treating obesity as a chronic condition. Combines time-restricted eating (TRE), behavioural coaching, peer-led support, and whole-food dietary guidance delivered through a mobile app. Led by NHS obesity specialists with multidisciplinary clinical teams. Designed for use with or without pharmacotherapy. NICE-evaluated with time-limited recommendation for early use within the NHS until March 2028.
- Roczen Plus Medication-assisted weight management programme combining the Roczen clinical programme with GLP-1/GIP or GLP-1 weight-loss medications (Wegovy, Mounjaro). Includes doctor-prescribed weekly medication doses, one-to-one clinician guidance, monthly check-ins, personalised diet and exercise plans, HbA1c blood testing, and app access with community support. Subscription starts from £195 per month.
Quantifiable outcome
- Mean weight loss of 8.6kg (-8.7%) at 12 months across diverse patient population (n=132, p<0.0001)
- +7 more outcomes
Companies that use Reset Health
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles5 records
Reset Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature5 records
Reset Health partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, strategic and minor.
- East Suffolk and North Essex NHS Foundation Trust (ESNEFT)coreClinical partnership to transform specialist obesity services, reducing waiting times from 2 years to 8 days, eliminating out-of-area placements, and moving 1,600+ appointments out of secondary care. Reset Health provides its integrated care platform enabling personalised multidisciplinary care through virtual consultations, clinical messaging, and long-term outcome monitoring.
- Suffolk and North East Essex Integrated Care Board (SNEE ICB)coreJoint partnership with ESNEFT to transform specialist obesity services across the region. ICB partners with Reset Health to deliver digitally enabled, locally delivered complex obesity care that is genuinely personalised and accessible.
- Pharmacy2UcoreStrategic partnership with UK's largest online pharmacy to deliver end-to-end obesity treatment and care. Combines rapid GLP-1 access through Pharmacy2U with expert clinical wraparound care from Reset Health. Launches Q1 2026.
- AffideacorePan-European strategic long-term collaboration to launch Roczen to Affidea's 14 million patients. Roczen will be rolled out across Affidea markets providing personalised obesity and Type 2 diabetes care combining sustainable lifestyle changes with medical interventions.
- IQVIAstrategicJoint white paper partnership exploring NHS concerns around obesity care and providing a data-driven, digitally-enabled solution through a Community Obesity Management Service. Uses IQVIA's healthcare data expertise with Reset Health's Roczen platform.
- Novo NordiskstrategicPharmaceutical partner and GLP-1 manufacturer. Advisory board includes Pinder Sahota, former General Manager of Novo Nordisk UK. Reset Health supports patients using Novo Nordisk obesity medications with clinical wraparound care.
- Eli LillystrategicPharmaceutical partner and GLP-1/GIP manufacturer (Mounjaro/tirzepatide). Reset Health provides clinical support programmes for patients using Eli Lilly obesity medications.
- Zuellig PharmaminorPharmaceutical distributor partner providing access to medications and healthcare products across Asian markets where Reset Health operates.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
Reset Health competitors and assessment
Company assessmentEmerging players
- DarioHealth: Digital chronic condition management platform spanning diabetes, hypertension and obesity with strong B2B payer and employer focus. Comparable chronic-disease multimorbidity positioning and AI-driven personalised care pathways to Reset Health's RTP.
- CureApp: Regulated digital therapeutic company developing prescription DTx for conditions including obesity and metabolic disease. Comparable in pursuing regulatory-grade (NICE/MHRA-style) digital therapeutic designations and clinical governance around chronic conditions.
Broad incumbents
- Noom: Large-scale consumer digital weight-loss platform with growing GLP-1 companion offerings and enterprise health partnerships. Operates across the same end-user weight-loss category as Reset Health but with a much broader consumer brand and DTC focus.
- WeightWatchers (WW International): Incumbent weight-management brand now offering a clinical / GLP-1 pathway (WW Clinic) and employer programmes. Comparable consumer-plus-clinical model and employer GTM motion versus Reset's Roczen Plus and employer benefits offering.
- Babylon Health: UK-headquartered virtual care platform providing telehealth, chronic care and population health tools to NHS and global partners. Comparable to Reset Health's NHS-facing virtual care model, though operating at a broader primary-care level rather than obesity-specialised.
Direct peers
- Second Nature: UK digital weight-management programme combining app-based coaching, behaviour change and optional GLP-1 medication pathways, with NHS and employer contracts. Highly comparable to Roczen Plus in its consumer-plus-clinical model.
- Huma Therapeutics: Digital health platform powering regulated remote patient monitoring and chronic care pathways for health systems and pharma. Directly comparable to Reset Health's RTP in combining a regulated clinical platform with real-world data capture for life-sciences partners.
- Liva Healthcare: Digital chronic disease prevention and management platform offering coach-led programmes for obesity, diabetes and cardiovascular disease across European health systems. Directly competes with Roczen for NHS-tier-3 weight management and DPP commissioning.
- Oviva: Europe-based digital behaviour-change programme for obesity, type 2 diabetes and related metabolic conditions delivered via app and coach support. Closely mirrors Reset's Roczen programme in combining multidisciplinary coaching with GLP-1-era wraparound care.
Regional players
- Vitality Health: UK health and life insurer with member wellness and chronic-condition management programmes, including weight management. Comparable employer/payer channel for chronic metabolic care, though primarily insurer-led rather than a standalone digital health platform.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Reset Health social profiles
Digital presenceReset Health compliance and trust
Trust signalCompliance3 records
Reset Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Reset Health leadership team
Management profileNumber of profiles
Profiles25 records
Reset Health subsidiaries and ownership
Company hierarchySubsidiaries1 record
Reset Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Reset Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Reset Health
What does Reset Health do?
Reset Health designs and delivers clinically led, technology-enabled chronic care programmes for obesity, type 2 diabetes, and metabolic syndrome through its proprietary Reset Technology Platform (RTP) and Roczen care model. It combines multidisciplinary clinical teams (doctors, dietitians, nurses, psychologists) with a digital platform, offering B2B partnerships (NHS health systems, employers, pharmaceutical companies, private providers) as well as direct-to-consumer subscription services (Roczen Plus). The platform supports white-label deployment and integrates GLP-1/GIP pharmacotherapy with structured behavioural and dietary interventions.
Is Reset Health a public or private company?
Reset Health is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Reset Health founded?
Reset Health was founded in 2019. It employs 1 to 10 people.
Where is Reset Health based?
Reset Health is headquartered in London, United Kingdom, in the Europe region.
How does Reset Health make money?
Five revenue lines are on record. NHS and Health System Contracts are the primary driver. The others are employer Health Benefits, pharma & Life Sciences Partnerships, direct-to-Consumer (Roczen Plus) and private Provider Partnerships.
Who are Reset Health's main competitors?
Emerging players on record are DarioHealth and CureApp. Broad incumbents are Noom, WeightWatchers (WW International) and Babylon Health. Direct peers are Second Nature, Huma Therapeutics, Liva Healthcare and Oviva. Vitality Health is listed as a regional player.
Does Reset Health have an API?
No public API is recorded for Reset Health.
What industry is Reset Health in?
Reset Health's product category is Digital Health Services. Its primary akta.pro industry code is HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity), with a secondary code of HLALAIAH, Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing. Its NAICS code is 812191 and its SIC code is 8000.